IHHCPL plans to open a state-of-the-art assisted living centre in March 2023, to expand to 1000 units within the next 24 months
Indrayani Biotech informed that its wholly-owned subsidiary M/S IBL Healthcare has acquired a 51 per cent stake in India Home Health Care Private Limited (IHHCPL). IBL Healthcare has acquired 52,970 equity shares of India Home Health Care. Consequently, it has become a subsidiary company of IBL Healthcare. The company has paid a consideration of Rs 52.96 lakh.
Orthopaedic care, cancer care, critical care, neuro care, tracheostomy and ventilator care, palliative care, geriatric care, postsurgical care, and wellness services are all available at IHHCPL.
IHHCPL is quickly becoming a reliable partner for leading Clinical Research Organizations (CRO) conducting clinical trials in the US and Europe, having already made significant inroads into this segment under the brand name Avatar.
Avatar expects to generate approximately $6 million in revenue over the next 36 months, up from the current run rate of $500 thousand.
IHHCPL plans to open a state-of-the-art assisted living centre in March 2023, to expand to 1000 units within the next 24 months.